{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:02:11Z","timestamp":1792692131547,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003243","name":"ministerstvo zdravotnictv\u00ed cesk\u00e9 republiky","doi-asserted-by":"publisher","award":["MH CZ DRO-VFN 64165"],"award-info":[{"award-number":["MH CZ DRO-VFN 64165"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"ministerstvo zdravotnictv\u00ed cesk\u00e9 republiky","doi-asserted-by":"publisher","award":["AZV NU22-03-00122"],"award-info":[{"award-number":["AZV NU22-03-00122"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"univerzita karlova v praze","doi-asserted-by":"publisher","award":["Progress Q28\/LF1"],"award-info":[{"award-number":["Progress Q28\/LF1"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"univerzita karlova v praze","doi-asserted-by":"publisher","award":["UNCE204065"],"award-info":[{"award-number":["UNCE204065"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"european regional development fund","doi-asserted-by":"publisher","award":["CZ.02.1.01\/0.0\/0.0\/18_046\/0015959"],"award-info":[{"award-number":["CZ.02.1.01\/0.0\/0.0\/18_046\/0015959"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"european regional development fund","doi-asserted-by":"publisher","award":["BBMRI_CZ LM2018125"],"award-info":[{"award-number":["BBMRI_CZ LM2018125"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00428-021-03217-z","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T13:55:20Z","timestamp":1633874120000},"page":"281-291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Uterine cellular leiomyomas are characterized by common HMGA2 aberrations, followed by chromosome 1p deletion and MED12 mutation: morphological, molecular, and immunohistochemical study of 52 cases"],"prefix":"10.1007","volume":"480","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8940-6124","authenticated-orcid":false,"given":"Pavel","family":"Dundr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ria","family":"Gregov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hojn\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Krkavcov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana","family":"Mich\u00e1lkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krist\u00fdna","family":"N\u011bmejcov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"B\u00e1rt\u016f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"H\u00e1jkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Laco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"M\u00e1ra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad\u00e9la","family":"Richt\u00e1rov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"Zima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Stru\u017einsk\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,9]]},"reference":[{"issue":"7","key":"3217_CR1","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1097\/00000478-199507000-00003","volume":"19","author":"E Oliva","year":"1995","unstructured":"Oliva E et al (1995) Cellular benign mesenchymal tumors of the uterus. A comparative morphologic and immunohistochemical analysis of 33 highly cellular leiomyomas and six endometrial stromal nodules, two frequently confused tumors. Am J Surg Pathol 19(7):757\u201368","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"3217_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1028-4559(10)60043-5","volume":"49","author":"S Roy","year":"2010","unstructured":"Roy S, Saroha V, Jain D (2010) Highly cellular leiomyoma mimics a malignant small round-cell tumor: a diagnostic dilemma on frozen sections. Taiwan J Obstet Gynecol 49(2):203\u2013205","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"2","key":"3217_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/00129039-200106000-00009","volume":"9","author":"SN Agoff","year":"2001","unstructured":"Agoff SN et al (2001) Immunohistochemical distinction of endometrial stromal sarcoma and cellular leiomyoma. Appl Immunohistochem Mol Morphol 9(2):164\u2013169","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"4","key":"3217_CR4","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/PGP.0000000000000141","volume":"33","author":"E Oliva","year":"2014","unstructured":"Oliva E (2014) Cellular mesenchymal tumors of the uterus: a review emphasizing recent observations. Int J Gynecol Pathol 33(4):374\u2013384","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"3217_CR5","first-page":"31","volume":"6","author":"M Pujani","year":"2015","unstructured":"Pujani M et al (2015) Cellular leiomyoma versus endometrial stromal tumor: a pathologists\u2019 dilemma. J Midlife Health 6(1):31\u201334","journal-title":"J Midlife Health"},{"issue":"3","key":"3217_CR6","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.fertnstert.2014.06.050","volume":"102","author":"M Mehine","year":"2014","unstructured":"Mehine M et al (2014) Genomics of uterine leiomyomas: insights from high-throughput sequencing. Fertil Steril 102(3):621\u2013629","journal-title":"Fertil Steril"},{"issue":"5","key":"3217_CR7","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1073\/pnas.1518752113","volume":"113","author":"M Mehine","year":"2016","unstructured":"Mehine M et al (2016) Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers. Proc Natl Acad Sci U S A 113(5):1315\u20131320","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3217_CR8","doi-asserted-by":"crossref","unstructured":"Mehine, M., et al., 3'RNA Sequencing accurately classifies formalin-fixed paraffin-embedded uterine leiomyomas. Cancers (Basel), 2020. 12(12).","DOI":"10.3390\/cancers12123839"},{"issue":"7","key":"3217_CR9","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/ijc.27424","volume":"131","author":"DN Markowski","year":"2012","unstructured":"Markowski DN et al (2012) MED12 mutations in uterine fibroids\u2013their relationship to cytogenetic subgroups. Int J Cancer 131(7):1528\u20131536","journal-title":"Int J Cancer"},{"issue":"3","key":"3217_CR10","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s12253-019-00739-5","volume":"26","author":"M Gregova","year":"2020","unstructured":"Gregova M et al (2020) Leiomyoma with bizarre nuclei: a study of 108 cases focusing on clinicopathological features, morphology, and fumarate hydratase alterations. Pathol Oncol Res 26(3):1527\u20131537","journal-title":"Pathol Oncol Res"},{"issue":"7","key":"3217_CR11","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/modpathol.2013.215","volume":"27","author":"C Reyes","year":"2014","unstructured":"Reyes C et al (2014) Uterine smooth muscle tumors with features suggesting fumarate hydratase aberration: detailed morphologic analysis and correlation with S-(2-succino)-cysteine immunohistochemistry. Mod Pathol 27(7):1020\u20131027","journal-title":"Mod Pathol"},{"key":"3217_CR12","unstructured":"Zhang, Q., et al., Fumarate hydratase mutations and alterations in leiomyoma with bizarre nuclei. Int J Gynecol Pathol, 2017."},{"issue":"8","key":"3217_CR13","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/modpathol.2013.243","volume":"27","author":"E Bertsch","year":"2014","unstructured":"Bertsch E et al (2014) MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma. Mod Pathol 27(8):1144\u20131153","journal-title":"Mod Pathol"},{"issue":"1","key":"3217_CR14","doi-asserted-by":"publisher","first-page":"17050","DOI":"10.1038\/s41598-019-53636-x","volume":"9","author":"I Ticha","year":"2019","unstructured":"Ticha I et al (2019) A comprehensive evaluation of pathogenic mutations in primary cutaneous melanomas, including the identification of novel loss-of-function variants. Sci Rep 9(1):17050","journal-title":"Sci Rep"},{"issue":"1","key":"3217_CR15","doi-asserted-by":"publisher","first-page":"6958","DOI":"10.1038\/s41598-020-63733-x","volume":"10","author":"J Hojny","year":"2020","unstructured":"Hojny J et al (2020) Identification of novel HNF1B mRNA splicing variants and their qualitative and semi-quantitative profile in selected healthy and tumour tissues. Sci Rep 10(1):6958","journal-title":"Sci Rep"},{"issue":"5","key":"3217_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/bio.2015.0032","volume":"13","author":"LJ Carithers","year":"2015","unstructured":"Carithers LJ et al (2015) A Novel Approach to High-Quality Postmortem Tissue Procurement: The GTEx Project. Biopreserv Biobank 13(5):311\u2013319","journal-title":"Biopreserv Biobank"},{"issue":"5","key":"3217_CR17","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/modpathol.3880335","volume":"14","author":"PG Chu","year":"2001","unstructured":"Chu PG et al (2001) Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Mod Pathol 14(5):465\u2013471","journal-title":"Mod Pathol"},{"issue":"3","key":"3217_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1046\/j.1365-2559.2001.01215.x","volume":"39","author":"WG McCluggage","year":"2001","unstructured":"McCluggage WG, Sumathi VP, Maxwell P (2001) CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. Histopathology 39(3):273\u2013278","journal-title":"Histopathology"},{"issue":"4","key":"3217_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/00000478-200104000-00004","volume":"25","author":"MR Nucci","year":"2001","unstructured":"Nucci MR et al (2001) h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors. Am J Surg Pathol 25(4):455\u2013463","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"3217_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/00000478-200204000-00001","volume":"26","author":"E Oliva","year":"2002","unstructured":"Oliva E et al (2002) An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies. Am J Surg Pathol 26(4):403\u2013412","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"3217_CR21","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/modpathol.2013.123","volume":"27","author":"CE Parra-Herran","year":"2014","unstructured":"Parra-Herran CE et al (2014) Targeted development of specific biomarkers of endometrial stromal cell differentiation using bioinformatics: the IFITM1 model. Mod Pathol 27(4):569\u2013579","journal-title":"Mod Pathol"},{"issue":"2","key":"3217_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/00000478-200102000-00014","volume":"25","author":"DS Rush","year":"2001","unstructured":"Rush DS et al (2001) h-Caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma. Am J Surg Pathol 25(2):253\u2013258","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"3217_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ygyno.2003.08.038","volume":"92","author":"XQ Zhu","year":"2004","unstructured":"Zhu XQ et al (2004) Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma. Gynecol Oncol 92(1):71\u201379","journal-title":"Gynecol Oncol"},{"issue":"3","key":"3217_CR24","first-page":"2795","volume":"8","author":"MM Allen","year":"2015","unstructured":"Allen MM et al (2015) An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas. Int J Clin Exp Pathol 8(3):2795\u20132801","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"3217_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/00004347-199901000-00004","volume":"18","author":"YL Zhai","year":"1999","unstructured":"Zhai YL et al (1999) Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas. Int J Gynecol Pathol 18(1):20\u201328","journal-title":"Int J Gynecol Pathol"},{"key":"3217_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.humpath.2017.12.005","volume":"76","author":"Q Zhang","year":"2018","unstructured":"Zhang Q et al (2018) The selected biomarker analysis in 5 types of uterine smooth muscle tumors. Hum Pathol 76:17\u201327","journal-title":"Hum Pathol"},{"key":"3217_CR27","doi-asserted-by":"crossref","unstructured":"Hodgson, A., et al., Gene fusions characterize a subset of uterine cellular leiomyomas. Genes Chromosomes Cancer, 2020.","DOI":"10.1002\/gcc.22888"},{"issue":"2","key":"3217_CR28","first-page":"86","volume":"57","author":"P Dundr","year":"2021","unstructured":"Dundr P et al (2021) The value of immunohistochemical methods in diagnosing mesenchymal tumours of the uterus. Cesk Patol 57(2):86\u201395","journal-title":"Cesk Patol"},{"issue":"2","key":"3217_CR29","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ejogrb.2013.10.004","volume":"171","author":"R Rothmund","year":"2013","unstructured":"Rothmund R et al (2013) Clinical and pathological characteristics, pathological reevaluation and recurrence patterns of cellular leiomyomas: a retrospective study in 76 patients. Eur J Obstet Gynecol Reprod Biol 171(2):358\u2013361","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"3217_CR30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0002-9378(77)90582-8","volume":"129","author":"SD Gisser","year":"1977","unstructured":"Gisser SD, Young I (1977) Neurilemoma-like uterine myomas: an ultrastructural reaffirmation of their non-Schwannian nature. Am J Obstet Gynecol 129(4):389\u2013392","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"3217_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1346-8138.2002.tb00240.x","volume":"29","author":"MW Lee","year":"2002","unstructured":"Lee MW et al (2002) Palisaded and verocay body prominent leiomyoma of deep soft tissue. J Dermatol 29(3):160\u2013163","journal-title":"J Dermatol"},{"issue":"5","key":"3217_CR32","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/jclinpath-2014-202829","volume":"68","author":"RH Ali","year":"2015","unstructured":"Ali RH, Rouzbahman M (2015) Endometrial stromal tumours revisited: an update based on the 2014 WHO classification. J Clin Pathol 68(5):325\u2013332","journal-title":"J Clin Pathol"},{"issue":"5","key":"3217_CR33","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1097\/00000478-200205000-00003","volume":"26","author":"A Dionigi","year":"2002","unstructured":"Dionigi A et al (2002) Endometrial stromal nodules and endometrial stromal tumors with limited infiltration: a clinicopathologic study of 50 cases. Am J Surg Pathol 26(5):567\u2013581","journal-title":"Am J Surg Pathol"},{"key":"3217_CR34","doi-asserted-by":"crossref","unstructured":"Busca, A., et al., IFITM1 outperforms CD10 in differentiating low-grade endometrial stromal sarcomas from smooth muscle neoplasms of the uterus. Int J Gynecol Pathol, 2017.","DOI":"10.1097\/PGP.0000000000000424"},{"issue":"11","key":"3217_CR35","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/ejhg.2013.33","volume":"21","author":"N Makinen","year":"2013","unstructured":"Makinen N et al (2013) MED12 exon 2 mutations in histopathological uterine leiomyoma variants. Eur J Hum Genet 21(11):1300\u20131303","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"3217_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12943-017-0672-1","volume":"16","author":"N Makinen","year":"2017","unstructured":"Makinen N et al (2017) Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors. Mol Cancer 16(1):101","journal-title":"Mol Cancer"},{"issue":"10","key":"3217_CR37","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1093\/humrep\/deaa187","volume":"35","author":"A \u00c4yr\u00e4v\u00e4inen","year":"2020","unstructured":"\u00c4yr\u00e4v\u00e4inen A et al (2020) Systematic molecular and clinical analysis of uterine leiomyomas from fertile-aged women undergoing myomectomy. Hum Reprod 35(10):2237\u20132244","journal-title":"Hum Reprod"},{"issue":"4","key":"3217_CR38","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/his.12039","volume":"62","author":"A Matsubara","year":"2013","unstructured":"Matsubara A et al (2013) Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours. Histopathology 62(4):657\u2013661","journal-title":"Histopathology"},{"issue":"6053","key":"3217_CR39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1126\/science.1208930","volume":"334","author":"N Makinen","year":"2011","unstructured":"Makinen N et al (2011) MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science 334(6053):252\u2013255","journal-title":"Science"},{"issue":"12","key":"3217_CR40","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1016\/j.celrep.2019.11.077","volume":"29","author":"JW George","year":"2019","unstructured":"George JW et al (2019) Integrated epigenome, exome, and transcriptome analyses reveal molecular subtypes and homeotic transformation in uterine fibroids. Cell Rep 29(12):4069-4085.e6","journal-title":"Cell Rep"},{"issue":"1","key":"3217_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cancergencyto.2010.06.002","volume":"202","author":"GV Velagaleti","year":"2010","unstructured":"Velagaleti GV et al (2010) Fusion of HMGA2 to COG5 in uterine leiomyoma. Cancer Genet Cytogenet 202(1):11\u201316","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"3217_CR42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1056\/NEJMoa1302736","volume":"369","author":"M Mehine","year":"2013","unstructured":"Mehine M et al (2013) Characterization of uterine leiomyomas by whole-genome sequencing. N Engl J Med 369(1):43\u201353","journal-title":"N Engl J Med"},{"issue":"6","key":"3217_CR43","first-page":"1351","volume":"63","author":"BJ Quade","year":"2003","unstructured":"Quade BJ et al (2003) Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15. Cancer Res 63(6):1351\u20131358","journal-title":"Cancer Res"},{"issue":"1","key":"3217_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0002-9440(10)63091-X","volume":"164","author":"R Lehtonen","year":"2004","unstructured":"Lehtonen R et al (2004) Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors. Am J Pathol 164(1):17\u201322","journal-title":"Am J Pathol"},{"issue":"11","key":"3217_CR45","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1097\/PAS.0000000000000520","volume":"39","author":"NM Joseph","year":"2015","unstructured":"Joseph NM et al (2015) Morphology and immunohistochemistry for 2SC and FH aid in detection of fumarate hydratase gene aberrations in uterine leiomyomas from young patients. Am J Surg Pathol 39(11):1529\u20131539","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"3217_CR46","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/sj.bjc.6600502","volume":"87","author":"KT Barker","year":"2002","unstructured":"Barker KT et al (2002) Low frequency of somatic mutations in the FH\/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas. Br J Cancer 87(4):446\u2013448","journal-title":"Br J Cancer"},{"issue":"3","key":"3217_CR47","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gcc.20291","volume":"45","author":"NC Christacos","year":"2006","unstructured":"Christacos NC et al (2006) Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features. Genes Chromosomes Cancer 45(3):304\u2013312","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"3217_CR48","doi-asserted-by":"publisher","first-page":"572.e1","DOI":"10.1016\/j.ajog.2014.01.011","volume":"210","author":"JC Hodge","year":"2014","unstructured":"Hodge JC et al (2014) Uterine cellular leiomyomata with chromosome 1p deletions represent a distinct entity. Am J Obstet Gynecol 210(6):572.e1\u20137","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"3217_CR49","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.ygyno.2018.07.007","volume":"150","author":"LJ Galindo","year":"2018","unstructured":"Galindo LJ et al (2018) HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas. Gynecol Oncol 150(3):562\u2013568","journal-title":"Gynecol Oncol"},{"issue":"5","key":"3217_CR50","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/14737159.2017.1311790","volume":"17","author":"B Davidson","year":"2017","unstructured":"Davidson B, Micci F (2017) Molecular characteristics of uterine sarcomas. Expert Rev Mol Diagn 17(5):515\u2013522","journal-title":"Expert Rev Mol Diagn"},{"issue":"2","key":"3217_CR51","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0165-4608(91)90073-4","volume":"55","author":"C Sreekantaiah","year":"1991","unstructured":"Sreekantaiah C et al (1991) An endometrial stromal sarcoma with clonal cytogenetic abnormalities. Cancer Genet Cytogenet 55(2):163\u2013166","journal-title":"Cancer Genet Cytogenet"},{"issue":"11","key":"3217_CR52","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/gcc.22380","volume":"55","author":"F Micci","year":"2016","unstructured":"Micci F et al (2016) Cytogenetic and molecular profile of endometrial stromal sarcoma. Genes Chromosomes Cancer 55(11):834\u2013846","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"3217_CR53","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.canlet.2014.01.030","volume":"347","author":"F Micci","year":"2014","unstructured":"Micci F et al (2014) MEAF6\/PHF1 is a recurrent gene fusion in endometrial stromal sarcoma. Cancer Lett 347(1):75\u201378","journal-title":"Cancer Lett"},{"key":"3217_CR54","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.humpath.2018.12.006","volume":"86","author":"M Miettinen","year":"2019","unstructured":"Miettinen M et al (2019) New fusion sarcomas: histopathology and clinical significance of selected entities. Hum Pathol 86:57\u201365","journal-title":"Hum Pathol"},{"issue":"11","key":"3217_CR55","doi-asserted-by":"publisher","first-page":"6348","DOI":"10.1073\/pnas.101132598","volume":"98","author":"JI Koontz","year":"2001","unstructured":"Koontz JI et al (2001) Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci U S A 98(11):6348\u20136353","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3217_CR56","doi-asserted-by":"crossref","unstructured":"Mansor, S., et al., ZC3H7B-BCOR-Rearranged endometrial stromal sarcomas: a distinct subset merits its own classification? Int J Gynecol Pathol, 2018.","DOI":"10.1097\/PGP.0000000000000523"},{"key":"3217_CR57","doi-asserted-by":"crossref","unstructured":"Ondic, O., et al., ZC3H7B-BCOR high-grade endometrial stromal sarcoma may present as myoma nascens with cytoplasmic signet ring cell change. Virchows Arch, 2020.","DOI":"10.1007\/s00428-020-02744-5"},{"issue":"1","key":"3217_CR58","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1158\/0008-5472.CAN-05-2485","volume":"66","author":"F Micci","year":"2006","unstructured":"Micci F et al (2006) Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1\/PHF1 and EPC1\/PHF1 in endometrial stromal sarcoma. Cancer Res 66(1):107\u2013112","journal-title":"Cancer Res"},{"issue":"7","key":"3217_CR59","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/gcc.22057","volume":"52","author":"I Panagopoulos","year":"2013","unstructured":"Panagopoulos I et al (2013) Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22-translocation. Genes Chromosomes Cancer 52(7):610\u2013618","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"3217_CR60","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/ijc.28440","volume":"134","author":"B Dewaele","year":"2014","unstructured":"Dewaele B et al (2014) Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcoma. Int J Cancer 134(5):1112\u20131122","journal-title":"Int J Cancer"},{"issue":"2","key":"3217_CR61","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.pathol.2017.11.086","volume":"50","author":"L Hoang","year":"2018","unstructured":"Hoang L, Chiang S, Lee CH (2018) Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations. Pathology 50(2):162\u2013177","journal-title":"Pathology"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-021-03217-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-021-03217-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-021-03217-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T17:22:52Z","timestamp":1725902572000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-021-03217-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,9]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["3217"],"URL":"https:\/\/doi.org\/10.1007\/s00428-021-03217-z","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,9]]},"assertion":[{"value":"30 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the Ethics Committee of General University Hospital in Prague in compliance with the Helsinki Declaration (ethical approval number EK RVO 210\/19 S-IV). The Ethics Committee waived the requirement for informed consent, as according to the Czech Law (Act. no. 373\/11, and its amendment Act no. 202\/17) it is not necessary to obtain informed consent in fully anonymized studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}